Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Postsynaptic congenital myasthenic syndrome
Congenital myasthenic syndrome 3A
A congenital myasthenic syndrome characterized by autosomal dominant inheritance of postsynaptic neuromuscular junction defects resulting in prolonged synaptic currents and early-onset progressive muscle weakness that has material basis in heterozygous mutation in the CHRND gene on chromosome 2q37.
This condition has no sub-types.